New microbleed after blood-brain barrier leakage in intracerebral haemorrhage

Koen M van Nieuwenhuizen1, Jeroen Hendrikse2, Catharina J M Klijn1,3

  • 1Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.

BMJ Case Reports
|April 29, 2017
PubMed

Insights

Cerebral microbleeds, indicators of small vessel disease, may develop after blood-brain barrier disruption. This case study links contrast enhancement, indicating BBB breakdown, to subsequent microbleed formation.

Area of Science:

  • Neurology
  • Neuroimaging
  • Vascular Neurology

Background:

  • Cerebral microbleeds (CMBs) are key indicators of small vessel disease.
  • Chronic blood-brain barrier (BBB) disruption is a proposed mechanism for CMB development.
  • Understanding CMB pathogenesis is crucial for managing cerebrovascular diseases.

Observation:

  • A 51-year-old male presented with two lobar intracerebral hemorrhages (ICHs) within two years.
  • MRI revealed multiple CMBs surrounding the ICHs, but not elsewhere.
  • A contrast-enhancing lesion appeared in the right occipital lobe 10 months post-ICH.

Findings:

  • A new CMB developed at the site of the prior contrast enhancement 20 months after the last ICH.
  • This temporal and spatial correlation suggests a link between BBB disruption and CMB formation.
  • CMBs were localized to hemorrhage sites, not distant areas.

Implications:

  • This case provides direct evidence that BBB disruption can precede and potentially cause CMBs.
  • Identifying BBB breakdown may offer new therapeutic targets for preventing CMBs.
  • Further research into BBB integrity is warranted for small vessel disease management.